Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity

Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 733,719 shares of HALO, which is worth approximately $43.4 Million. The most recent transaction as insider was on Feb 10, 2021, when has been sold 15,509 shares (Common Stock) at a price of $50.6 per share, resulting in proceeds of $784,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 734K

10.05% 3M change

8.42% 12M change

Total Value Held $43.4 Million

Helen Torley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2021	SELL Payment of exercise price or tax liability	$784,755 $50.6 p/Share	15,509 Reduced 3.09%	486,295 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	-	31,282 Added 5.87%	501,804 Common Stock
Feb 01 2021	SELL Open market or private sale	$2,406,500 $48.13 p/Share	50,000 Reduced 9.61%	470,522 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$733,000 $14.66 p/Share	50,000 Added 8.76%	520,522 Common Stock
Nov 30 2020	SELL Bona fide gift	-	10,000 Reduced 2.08%	470,522 Common Stock
Nov 25 2020	SELL Open market or private sale	$2,033,500 $40.67 p/Share	50,000 Reduced 9.42%	480,522 Common Stock
Nov 25 2020	BUY Exercise of conversion of derivative security	$733,000 $14.66 p/Share	50,000 Added 8.61%	530,522 Common Stock

Also insider at

DGX

QUEST DIAGNOSTICS INC Healthcare

Director

Helen Torley

PRESIDENT AND CEO

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Value

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO

Account